ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical CDMO Solution Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-34S12896
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical CDMO Solution Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical CDMO Solution Market Research Report 2025

Code: QYRE-Auto-34S12896
Report
April 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Recipharm
Lonza Group
Catalent
Patheon (Thermo Fisher Scientific)
Siegfried
Curia
Societal CDMO
Aenova Group
Eurofins CDMO
Piramal Group
WuXi AppTec Group
Fareva
Strides Pharma Science
SGS Quay Pharmaceuticals
Famar Health Care Service
Thermo Fisher Scientific
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Wuxi Biologics
Asymchem
Pfizer CentreOne

Pharmaceutical CDMO Solution Market Size

The global market for Pharmaceutical CDMO Solution was valued at US$ 147720 million in the year 2024 and is projected to reach a revised size of US$ 246510 million by 2031, growing at a CAGR of 7.7% during the forecast period.

Pharmaceutical CDMO Solution Market

Pharmaceutical CDMO Solution Market

Pharmaceutical CDMO (Contract Development and Manufacturing Organization) solutions refer to the services offered by companies that provide end-to-end outsourcing services to the pharmaceutical industry. CDMOs partner with pharmaceutical companies to assist in various stages of drug development, from early-stage research and development (R&D) to commercial-scale manufacturing and distribution.
The pharmaceutical Contract Development and Manufacturing Organization (CDMO) industry has experienced significant growth and transformation in recent years. CDMOs play a crucial role in supporting pharmaceutical companies by providing a wide range of services to expedite drug development and manufacturing processes. Pharmaceutical companies increasingly rely on CDMOs to access specialized expertise, advanced technologies, and cost-effective solutions, enabling them to focus on core research and marketing activities. The rising complexity of drug development, along with increasing regulatory requirements, has led to a higher demand for CDMO services, particularly in specialized areas like biologics, gene therapies, and personalized medicine. The United States and Canada are significant markets for pharmaceutical CDMOs due to a large number of biopharmaceutical companies and a robust outsourcing landscape. European countries, including the United Kingdom, Germany, and Switzerland, have a well-established pharmaceutical industry, contributing to a strong demand for CDMO services. Countries like India, China, and South Korea have emerged as major players in the CDMO market, offering cost-competitive services and advanced manufacturing capabilities. The global market for pharmaceutical CDMO solutions is expected to witness continued growth in the coming years, driven by increased outsourcing by pharmaceutical companies seeking specialized expertise, cost-effectiveness, and accelerated drug development timelines. Additionally, the ongoing advancements in biotechnology, gene therapies, and personalized medicine are likely to create new opportunities for CDMOs, as these cutting-edge areas require specialized capabilities and infrastructure.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO Solution.
The Pharmaceutical CDMO Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical CDMO Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical CDMO Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical CDMO Solution Market Report

Report Metric Details
Report Name Pharmaceutical CDMO Solution Market
Accounted market size in year US$ 147720 million
Forecasted market size in 2031 US$ 246510 million
CAGR 7.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Active Pharmaceutical Ingredient (API) Manufacturing
  • Finished Dosage Formulation (FDF) Development and Manufacturing
  • Secondary Packaging
  • Others
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Thermo Fisher Scientific, Samsung Biologics, Fujifilm Diosynth Biotechnologies, Societal CDMO, Aenova Group, Eurofins CDMO, Piramal Group, WuXi AppTec Group, Fareva, Strides Pharma Science, Famar Health Care Service, WuXi Biologics, Asymchem, Pfizer CentreOne
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical CDMO Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical CDMO Solution Market growing?

Ans: The Pharmaceutical CDMO Solution Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the Pharmaceutical CDMO Solution Market size in 2031?

Ans: The Pharmaceutical CDMO Solution Market size in 2031 will be US$ 246510 million.

Who are the main players in the Pharmaceutical CDMO Solution Market report?

Ans: The main players in the Pharmaceutical CDMO Solution Market are Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Thermo Fisher Scientific, Samsung Biologics, Fujifilm Diosynth Biotechnologies, Societal CDMO, Aenova Group, Eurofins CDMO, Piramal Group, WuXi AppTec Group, Fareva, Strides Pharma Science, Famar Health Care Service, WuXi Biologics, Asymchem, Pfizer CentreOne

What are the Application segmentation covered in the Pharmaceutical CDMO Solution Market report?

Ans: The Applications covered in the Pharmaceutical CDMO Solution Market report are Pharmaceutical Company, Biotechnology Company, Others

What are the Type segmentation covered in the Pharmaceutical CDMO Solution Market report?

Ans: The Types covered in the Pharmaceutical CDMO Solution Market report are Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging, Others

Recommended Reports

CDMO Services

Cell & Gene Therapy

Small Molecule CDMO

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Active Pharmaceutical Ingredient (API) Manufacturing
1.2.3 Finished Dosage Formulation (FDF) Development and Manufacturing
1.2.4 Secondary Packaging
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CDMO Solution Market Perspective (2020-2031)
2.2 Global Pharmaceutical CDMO Solution Growth Trends by Region
2.2.1 Global Pharmaceutical CDMO Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical CDMO Solution Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical CDMO Solution Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical CDMO Solution Market Dynamics
2.3.1 Pharmaceutical CDMO Solution Industry Trends
2.3.2 Pharmaceutical CDMO Solution Market Drivers
2.3.3 Pharmaceutical CDMO Solution Market Challenges
2.3.4 Pharmaceutical CDMO Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO Solution Players by Revenue
3.1.1 Global Top Pharmaceutical CDMO Solution Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical CDMO Solution Revenue
3.4 Global Pharmaceutical CDMO Solution Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Solution Revenue in 2024
3.5 Global Key Players of Pharmaceutical CDMO Solution Head office and Area Served
3.6 Global Key Players of Pharmaceutical CDMO Solution, Product and Application
3.7 Global Key Players of Pharmaceutical CDMO Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO Solution Breakdown Data by Type
4.1 Global Pharmaceutical CDMO Solution Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical CDMO Solution Breakdown Data by Application
5.1 Global Pharmaceutical CDMO Solution Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical CDMO Solution Market Size (2020-2031)
6.2 North America Pharmaceutical CDMO Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical CDMO Solution Market Size by Country (2020-2025)
6.4 North America Pharmaceutical CDMO Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CDMO Solution Market Size (2020-2031)
7.2 Europe Pharmaceutical CDMO Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical CDMO Solution Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical CDMO Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CDMO Solution Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical CDMO Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CDMO Solution Market Size (2020-2031)
9.2 Latin America Pharmaceutical CDMO Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical CDMO Solution Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical CDMO Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CDMO Solution Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical CDMO Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm AB
11.1.1 Recipharm AB Company Details
11.1.2 Recipharm AB Business Overview
11.1.3 Recipharm AB Pharmaceutical CDMO Solution Introduction
11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.1.5 Recipharm AB Recent Development
11.2 Lonza Group
11.2.1 Lonza Group Company Details
11.2.2 Lonza Group Business Overview
11.2.3 Lonza Group Pharmaceutical CDMO Solution Introduction
11.2.4 Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.2.5 Lonza Group Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Pharmaceutical CDMO Solution Introduction
11.3.4 Catalent Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Patheon (Thermo Fisher Scientific)
11.4.1 Patheon (Thermo Fisher Scientific) Company Details
11.4.2 Patheon (Thermo Fisher Scientific) Business Overview
11.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Introduction
11.4.4 Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.4.5 Patheon (Thermo Fisher Scientific) Recent Development
11.5 Siegfried AG
11.5.1 Siegfried AG Company Details
11.5.2 Siegfried AG Business Overview
11.5.3 Siegfried AG Pharmaceutical CDMO Solution Introduction
11.5.4 Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.5.5 Siegfried AG Recent Development
11.6 SGS Quay Pharmaceuticals
11.6.1 SGS Quay Pharmaceuticals Company Details
11.6.2 SGS Quay Pharmaceuticals Business Overview
11.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Introduction
11.6.4 SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.6.5 SGS Quay Pharmaceuticals Recent Development
11.7 Curia
11.7.1 Curia Company Details
11.7.2 Curia Business Overview
11.7.3 Curia Pharmaceutical CDMO Solution Introduction
11.7.4 Curia Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.7.5 Curia Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Pharmaceutical CDMO Solution Introduction
11.8.4 Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Details
11.9.2 Samsung Biologics Business Overview
11.9.3 Samsung Biologics Pharmaceutical CDMO Solution Introduction
11.9.4 Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.9.5 Samsung Biologics Recent Development
11.10 Fujifilm Diosynth Biotechnologies
11.10.1 Fujifilm Diosynth Biotechnologies Company Details
11.10.2 Fujifilm Diosynth Biotechnologies Business Overview
11.10.3 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Introduction
11.10.4 Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.10.5 Fujifilm Diosynth Biotechnologies Recent Development
11.11 Societal CDMO
11.11.1 Societal CDMO Company Details
11.11.2 Societal CDMO Business Overview
11.11.3 Societal CDMO Pharmaceutical CDMO Solution Introduction
11.11.4 Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.11.5 Societal CDMO Recent Development
11.12 Aenova Group
11.12.1 Aenova Group Company Details
11.12.2 Aenova Group Business Overview
11.12.3 Aenova Group Pharmaceutical CDMO Solution Introduction
11.12.4 Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.12.5 Aenova Group Recent Development
11.13 Eurofins CDMO
11.13.1 Eurofins CDMO Company Details
11.13.2 Eurofins CDMO Business Overview
11.13.3 Eurofins CDMO Pharmaceutical CDMO Solution Introduction
11.13.4 Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.13.5 Eurofins CDMO Recent Development
11.14 Piramal Group
11.14.1 Piramal Group Company Details
11.14.2 Piramal Group Business Overview
11.14.3 Piramal Group Pharmaceutical CDMO Solution Introduction
11.14.4 Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.14.5 Piramal Group Recent Development
11.15 WuXi AppTec Group
11.15.1 WuXi AppTec Group Company Details
11.15.2 WuXi AppTec Group Business Overview
11.15.3 WuXi AppTec Group Pharmaceutical CDMO Solution Introduction
11.15.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.15.5 WuXi AppTec Group Recent Development
11.16 Fareva
11.16.1 Fareva Company Details
11.16.2 Fareva Business Overview
11.16.3 Fareva Pharmaceutical CDMO Solution Introduction
11.16.4 Fareva Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.16.5 Fareva Recent Development
11.17 Strides Pharma Science
11.17.1 Strides Pharma Science Company Details
11.17.2 Strides Pharma Science Business Overview
11.17.3 Strides Pharma Science Pharmaceutical CDMO Solution Introduction
11.17.4 Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.17.5 Strides Pharma Science Recent Development
11.18 Famar Health Care Service
11.18.1 Famar Health Care Service Company Details
11.18.2 Famar Health Care Service Business Overview
11.18.3 Famar Health Care Service Pharmaceutical CDMO Solution Introduction
11.18.4 Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.18.5 Famar Health Care Service Recent Development
11.19 WuXi Biologics
11.19.1 WuXi Biologics Company Details
11.19.2 WuXi Biologics Business Overview
11.19.3 WuXi Biologics Pharmaceutical CDMO Solution Introduction
11.19.4 WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.19.5 WuXi Biologics Recent Development
11.20 Asymchem
11.20.1 Asymchem Company Details
11.20.2 Asymchem Business Overview
11.20.3 Asymchem Pharmaceutical CDMO Solution Introduction
11.20.4 Asymchem Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.20.5 Asymchem Recent Development
11.21 Pfizer CentreOne
11.21.1 Pfizer CentreOne Company Details
11.21.2 Pfizer CentreOne Business Overview
11.21.3 Pfizer CentreOne Pharmaceutical CDMO Solution Introduction
11.21.4 Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2020-2025)
11.21.5 Pfizer CentreOne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Recipharm
Lonza Group
Catalent
Patheon (Thermo Fisher Scientific)
Siegfried
Curia
Societal CDMO
Aenova Group
Eurofins CDMO
Piramal Group
WuXi AppTec Group
Fareva
Strides Pharma Science
SGS Quay Pharmaceuticals
Famar Health Care Service
Thermo Fisher Scientific
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Wuxi Biologics
Asymchem
Pfizer CentreOne
List of Tables
 Table 1. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Active Pharmaceutical Ingredient (API) Manufacturing
 Table 3. Key Players of Finished Dosage Formulation (FDF) Development and Manufacturing
 Table 4. Key Players of Secondary Packaging
 Table 5. Key Players of Others
 Table 6. Global Pharmaceutical CDMO Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmaceutical CDMO Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Pharmaceutical CDMO Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Pharmaceutical CDMO Solution Market Share by Region (2020-2025)
 Table 10. Global Pharmaceutical CDMO Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Pharmaceutical CDMO Solution Market Share by Region (2026-2031)
 Table 12. Pharmaceutical CDMO Solution Market Trends
 Table 13. Pharmaceutical CDMO Solution Market Drivers
 Table 14. Pharmaceutical CDMO Solution Market Challenges
 Table 15. Pharmaceutical CDMO Solution Market Restraints
 Table 16. Global Pharmaceutical CDMO Solution Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Pharmaceutical CDMO Solution Market Share by Players (2020-2025)
 Table 18. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2024)
 Table 19. Ranking of Global Top Pharmaceutical CDMO Solution Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Pharmaceutical CDMO Solution Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Pharmaceutical CDMO Solution, Headquarters and Area Served
 Table 22. Global Key Players of Pharmaceutical CDMO Solution, Product and Application
 Table 23. Global Key Players of Pharmaceutical CDMO Solution, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Pharmaceutical CDMO Solution Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2020-2025)
 Table 27. Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2026-2031)
 Table 29. Global Pharmaceutical CDMO Solution Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Pharmaceutical CDMO Solution Revenue Market Share by Application (2020-2025)
 Table 31. Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Pharmaceutical CDMO Solution Revenue Market Share by Application (2026-2031)
 Table 33. North America Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Pharmaceutical CDMO Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Pharmaceutical CDMO Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Pharmaceutical CDMO Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Pharmaceutical CDMO Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical CDMO Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Pharmaceutical CDMO Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharmaceutical CDMO Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Recipharm AB Company Details
 Table 49. Recipharm AB Business Overview
 Table 50. Recipharm AB Pharmaceutical CDMO Solution Product
 Table 51. Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 52. Recipharm AB Recent Development
 Table 53. Lonza Group Company Details
 Table 54. Lonza Group Business Overview
 Table 55. Lonza Group Pharmaceutical CDMO Solution Product
 Table 56. Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 57. Lonza Group Recent Development
 Table 58. Catalent Company Details
 Table 59. Catalent Business Overview
 Table 60. Catalent Pharmaceutical CDMO Solution Product
 Table 61. Catalent Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 62. Catalent Recent Development
 Table 63. Patheon (Thermo Fisher Scientific) Company Details
 Table 64. Patheon (Thermo Fisher Scientific) Business Overview
 Table 65. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product
 Table 66. Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 67. Patheon (Thermo Fisher Scientific) Recent Development
 Table 68. Siegfried AG Company Details
 Table 69. Siegfried AG Business Overview
 Table 70. Siegfried AG Pharmaceutical CDMO Solution Product
 Table 71. Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 72. Siegfried AG Recent Development
 Table 73. SGS Quay Pharmaceuticals Company Details
 Table 74. SGS Quay Pharmaceuticals Business Overview
 Table 75. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product
 Table 76. SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 77. SGS Quay Pharmaceuticals Recent Development
 Table 78. Curia Company Details
 Table 79. Curia Business Overview
 Table 80. Curia Pharmaceutical CDMO Solution Product
 Table 81. Curia Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 82. Curia Recent Development
 Table 83. Thermo Fisher Scientific Company Details
 Table 84. Thermo Fisher Scientific Business Overview
 Table 85. Thermo Fisher Scientific Pharmaceutical CDMO Solution Product
 Table 86. Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 87. Thermo Fisher Scientific Recent Development
 Table 88. Samsung Biologics Company Details
 Table 89. Samsung Biologics Business Overview
 Table 90. Samsung Biologics Pharmaceutical CDMO Solution Product
 Table 91. Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 92. Samsung Biologics Recent Development
 Table 93. Fujifilm Diosynth Biotechnologies Company Details
 Table 94. Fujifilm Diosynth Biotechnologies Business Overview
 Table 95. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product
 Table 96. Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 97. Fujifilm Diosynth Biotechnologies Recent Development
 Table 98. Societal CDMO Company Details
 Table 99. Societal CDMO Business Overview
 Table 100. Societal CDMO Pharmaceutical CDMO Solution Product
 Table 101. Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 102. Societal CDMO Recent Development
 Table 103. Aenova Group Company Details
 Table 104. Aenova Group Business Overview
 Table 105. Aenova Group Pharmaceutical CDMO Solution Product
 Table 106. Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 107. Aenova Group Recent Development
 Table 108. Eurofins CDMO Company Details
 Table 109. Eurofins CDMO Business Overview
 Table 110. Eurofins CDMO Pharmaceutical CDMO Solution Product
 Table 111. Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 112. Eurofins CDMO Recent Development
 Table 113. Piramal Group Company Details
 Table 114. Piramal Group Business Overview
 Table 115. Piramal Group Pharmaceutical CDMO Solution Product
 Table 116. Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 117. Piramal Group Recent Development
 Table 118. WuXi AppTec Group Company Details
 Table 119. WuXi AppTec Group Business Overview
 Table 120. WuXi AppTec Group Pharmaceutical CDMO Solution Product
 Table 121. WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 122. WuXi AppTec Group Recent Development
 Table 123. Fareva Company Details
 Table 124. Fareva Business Overview
 Table 125. Fareva Pharmaceutical CDMO Solution Product
 Table 126. Fareva Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 127. Fareva Recent Development
 Table 128. Strides Pharma Science Company Details
 Table 129. Strides Pharma Science Business Overview
 Table 130. Strides Pharma Science Pharmaceutical CDMO Solution Product
 Table 131. Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 132. Strides Pharma Science Recent Development
 Table 133. Famar Health Care Service Company Details
 Table 134. Famar Health Care Service Business Overview
 Table 135. Famar Health Care Service Pharmaceutical CDMO Solution Product
 Table 136. Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 137. Famar Health Care Service Recent Development
 Table 138. WuXi Biologics Company Details
 Table 139. WuXi Biologics Business Overview
 Table 140. WuXi Biologics Pharmaceutical CDMO Solution Product
 Table 141. WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 142. WuXi Biologics Recent Development
 Table 143. Asymchem Company Details
 Table 144. Asymchem Business Overview
 Table 145. Asymchem Pharmaceutical CDMO Solution Product
 Table 146. Asymchem Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 147. Asymchem Recent Development
 Table 148. Pfizer CentreOne Company Details
 Table 149. Pfizer CentreOne Business Overview
 Table 150. Pfizer CentreOne Pharmaceutical CDMO Solution Product
 Table 151. Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2020-2025) & (US$ Million)
 Table 152. Pfizer CentreOne Recent Development
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical CDMO Solution Picture
 Figure 2. Global Pharmaceutical CDMO Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical CDMO Solution Market Share by Type: 2024 VS 2031
 Figure 4. Active Pharmaceutical Ingredient (API) Manufacturing Features
 Figure 5. Finished Dosage Formulation (FDF) Development and Manufacturing Features
 Figure 6. Secondary Packaging Features
 Figure 7. Others Features
 Figure 8. Global Pharmaceutical CDMO Solution Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Pharmaceutical CDMO Solution Market Share by Application: 2024 VS 2031
 Figure 10. Pharmaceutical Company Case Studies
 Figure 11. Biotechnology Company Case Studies
 Figure 12. Others Case Studies
 Figure 13. Pharmaceutical CDMO Solution Report Years Considered
 Figure 14. Global Pharmaceutical CDMO Solution Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Pharmaceutical CDMO Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Pharmaceutical CDMO Solution Market Share by Region: 2024 VS 2031
 Figure 17. Global Pharmaceutical CDMO Solution Market Share by Players in 2024
 Figure 18. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Solution Revenue in 2024
 Figure 20. North America Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Pharmaceutical CDMO Solution Market Share by Country (2020-2031)
 Figure 22. United States Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pharmaceutical CDMO Solution Market Share by Country (2020-2031)
 Figure 26. Germany Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Pharmaceutical CDMO Solution Market Share by Region (2020-2031)
 Figure 34. China Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Pharmaceutical CDMO Solution Market Share by Country (2020-2031)
 Figure 42. Mexico Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Pharmaceutical CDMO Solution Market Share by Country (2020-2031)
 Figure 46. Turkey Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Pharmaceutical CDMO Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 50. Lonza Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 51. Catalent Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 52. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 53. Siegfried AG Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 54. SGS Quay Pharmaceuticals Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 55. Curia Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 57. Samsung Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 58. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 59. Societal CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 60. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 61. Eurofins CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 62. Piramal Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 63. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 64. Fareva Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 65. Strides Pharma Science Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 66. Famar Health Care Service Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 67. WuXi Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 68. Asymchem Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 69. Pfizer CentreOne Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Contract Dose Manufacturing Market Insights Forecast to 2030
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Formulation CDMO Services Market Research Report 2024
Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Full Service CDMO Market Research Report 2024
Global Pharmaceutical CDMO Market Research Report 2025
Pharmaceutical CDMO Services Market
Global Small Molecule Drug CDMO Services Market Research Report 2024
Global Chemical CDMO Market Research Report 2024
Global Bio Contract Development and Manufacturing Organizations CDMOs Market Insights Forecast to 2030
Global Biopharmaceutical CDMO Market Research Report 2025
Global Biopharmaceutical CDMO Service Market Research Report 2024
Global Biopharmaceutical and Bio CDMO Market Research Report 2024
Global Chemical Drug CDMO Market Research Report 2024
Global Oligonucleotide Drug CDMO Services Market Research Report 2024
Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecules CDMO Services Market Research Report 2024
Global Antibody Drug CDMO Service Market Research Report 2024
Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions